Efficacy of Antidepressants for Depression in Alzheimer's Disease: Systematic Review and Meta-Analysis

Journal of Alzheimer's Disease : JAD
Vasiliki OrgetaRobert Howard

Abstract

Depression is common in people with Alzheimer's disease (AD) affecting overall outcomes and decreasing quality of life. Although depression in AD is primarily treated with antidepressants, there are few randomized controlled trials (RCTs) assessing efficacy and results have been conflicting. To systematically review evidence on efficacy of antidepressant treatments for depression in AD. Systematic review and meta-analysis of double blind RCTs comparing antidepressants versus placebo for depression in AD. We searched MEDLINE, CINAHL, EMBASE, PsycINFO, the Cochrane Controlled Trials Register and on line national and international registers. Primary outcomes were treatment response and depressive symptoms. Secondary outcomes were cognition, acceptability, and tolerability. Risk of bias was also assessed. Seven studies met inclusion criteria. Three compared sertraline with placebo; one compared both sertraline and mirtazapine to placebo; imipramine, fluoxetine, and clomipramine were evaluated in one study each. In terms of response to treatment (6 studies, 297 patients treated with antidepressants and 223 with placebo), no statistically significant difference between antidepressants and placebo was found (odds ratio (OR) 1.95, 95% ...Continue Reading

References

Apr 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·S A Montgomery, M Asberg
May 1, 1991·Psychological Medicine·A BurnsR Levy
Jan 1, 1989·The American Journal of Psychiatry·B V ReiflerP McLean
Feb 1, 1988·Biological Psychiatry·G S AlexopoulosC A Shamoian
Jan 1, 1995·The American Journal of Psychiatry·R MigliorelliS E Starkstein
Jan 22, 1996·Journal of Affective Disorders·C BallardG Wilcock
Feb 1, 1996·The British Journal of Psychiatry : the Journal of Mental Science·M RothR Amrein
Jan 1, 1996·The Journal of Neuropsychiatry and Clinical Neurosciences·G PetraccaS E Starkstein
Feb 3, 1998·The Journal of Neuropsychiatry and Clinical Neurosciences·C G LyketsosA Warren
Jan 29, 2000·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·C MagaiD Gomberg
Aug 10, 2001·International Psychogeriatrics·G M PetraccaS E Starkstein
Feb 2, 2002·The British Journal of Psychiatry : the Journal of Mental Science·Alistair BurnsSarah Craig
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
Jun 19, 2004·BMJ : British Medical Journal·David AtkinsUNKNOWN GRADE Working Group
Dec 4, 2004·International Journal of Geriatric Psychiatry·Guk-Hee SuhJun-Young Lee
Nov 3, 2005·The American Journal of Psychiatry·Sergio E StarksteinRobert G Robinson
Oct 24, 2006·International Psychogeriatrics·Lars Vedel KessingPer Kragh Andersen
May 16, 2007·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Sarah ThompsonKrista L Lanctôt
Mar 21, 2008·Dementia and Geriatric Cognitive Disorders·Enrico MosselloNiccolò Marchionni
Nov 22, 2008·Archives of Gerontology and Geriatrics·P TagarielloM Amore
Jan 27, 2009·Medical Care·Joseph E GauglerJean F Wyman
Feb 7, 2009·BMJ : British Medical Journal·Alistair Burns, Steve Iliffe
Jan 21, 2010·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Paul B RosenbergUNKNOWN DIADS-2 Research Group
Oct 6, 2010·BMC Neurology·Manuel FernándezUNKNOWN COOPERA Study Group
Sep 20, 2011·Current Opinion in Psychiatry·Daniela EnacheDag Aarsland
Feb 20, 2014·JAMA : the Journal of the American Medical Association·Anton P PorsteinssonUNKNOWN CitAD Research Group
Sep 11, 2014·The Annals of Pharmacotherapy·Natalia M Jasiak, Jolene R Bostwick
Sep 12, 2014·Journal of Alzheimer's Disease : JAD·Ahmad A Khundakar, Alan J Thomas
Sep 30, 2014·Psychosomatics·Livia De PickerBernard G C Sabbe
Nov 22, 2014·International Psychogeriatrics·Marja-Liisa LaitinenSirpa Hartikainen
Mar 4, 2015·BMJ : British Medical Journal·Helen C KalesConstantine G Lyketsos
Mar 5, 2015·Expert Opinion on Drug Metabolism & Toxicology·Janet SultanaGianluca Trifirò
Sep 25, 2015·Journal of Alzheimer's Disease : JAD·Kostas T SiarkosAntonios M Politis
Oct 3, 2015·The British Journal of Psychiatry : the Journal of Mental Science·Vasiliki OrgetaMartin Orrell
Mar 1, 2016·International Journal of Geriatric Psychiatry·Arto PuranenSirpa Hartikainen
Sep 7, 2016·International Journal of Geriatric Psychiatry·Nicolas FarinaSube Banerjee

❮ Previous
Next ❯

Citations

Sep 1, 2018·The Cochrane Database of Systematic Reviews·Robert DudasTom Dening
Oct 28, 2018·Current Psychiatry Reports·David WolinskyJolene Bostwick
Mar 13, 2019·British Journal of Hospital Medicine·Lloyd D HughesDavid J Findlay
Jun 25, 2019·Current Treatment Options in Neurology·John M Ringman, Lon Schneider
Nov 1, 2018·Molecular Neurobiology·Luan Pereira DinizFlávia Carvalho Alcantara Gomes
Aug 23, 2019·Neurology and Therapy·Anna D BurkeSehar Khokher
Nov 22, 2019·European Journal of Clinical Pharmacology·Yun ZhangYehuan Sun
May 3, 2020·International Journal of Molecular Sciences·Ramon Cacabelos
Oct 28, 2019·Alzheimer Disease and Associated Disorders·Qurat Ul Ain KhanMaryam Zulfiqar
Jul 7, 2019·Current Psychiatry Reports·Kathleen S BinghamBenoit H Mulsant
Dec 12, 2018·Journal of Alzheimer's Disease : JAD·Lara HvidstenHege Kersten
May 20, 2019·Journal of Alzheimer's Disease : JAD·Richard J Elsworthy, Sarah Aldred
Jul 1, 2020·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Catherine McCombieVanessa C Lawrence
Jan 15, 2021·Molecular Neurodegeneration·Jeffrey Cummings
Nov 25, 2020·International Clinical Psychopharmacology·Fabio Lopes RochaDébora Pereira Thomaz
Mar 16, 2021·Frontiers in Psychiatry·Luis Agüera-OrtizJesús Porta-Etessam
Apr 15, 2021·Geriatrics & Gerontology International·Poonsri RangseekajeePongsatorn Paholpak
Apr 5, 2019·Neuroscience Letters·Saikat ChakrabortyHongxin Dong
May 11, 2021·Frontiers in Psychiatry·Ruben MuñizJavier Olazarán
Oct 21, 2020·Journal of the American Medical Directors Association·Enrico CallegariSverre Bergh
Aug 14, 2021·Indian Journal of Psychological Medicine·Subhashini K RangarajanGanesan Venkatasubramanian
Oct 20, 2020·Brain Research Bulletin·Hui ZhangXue-Mei Hao
Dec 30, 2021·Expert Opinion on Drug Safety·Javier De Diego-AdeliñoSelman F Salonia

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.